KetoSwiss: Startup developing treatment migraines raises $4 million · page 7 of 17
The slide uses a clinical trial context to validate the solution's efficacy.
Pitch deck · solution · present_solution · overcrowded density
Slide locked Sign in to view
Slide schematic 6/8
callout 0/1 image 1/1 list 1/1 metric 0/1 paragraph 1/1 source-note 1/1 title 2/2
2 without position callout 1 · metric 1
calloutmetric · primary
Components 8
callout illustration bullet primary paragraph source-note action-title headline
Tools 2
Data Story Arc slide · 70%
The slide presents data on the effectiveness of MigraKet, including a 19% reduction in migraine days and a 60% reduction in migraine days for responders.
Quantification slide · 60%The slide provides specific metrics, such as 19% and 60%, to support the claims about MigraKet's effectiveness.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.